| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/04/2006 | CN1234426C Topical pharmaceutical formulation |
| 01/04/2006 | CN1234417C Pharmaceutical compositions comprising dendritic cells for immunotherapy of automimmune disease and treatment methods using the same |
| 01/04/2006 | CN1234392C External drug of the Chinese traditional medicine for treating acne |
| 01/04/2006 | CN1234374C Ointment for treating pointed condyloma |
| 01/04/2006 | CN1234365C Compound preparation for treating psoriasis vulgaris and its preparation process |
| 01/04/2006 | CN1234341C Oily cosmetics and its praration |
| 01/03/2006 | US6982286 Bicarbocyclic hydrazine/hydrazide compounds as inhibitors of semicarbazide-sensitive amine oxidases (SSAO), treat an inflammatory disease or condition, a disease related to carbohydrate metabolism, smooth muscle cell function |
| 01/03/2006 | US6982277 Antitumor agents, antiinflammatory agents; for example 2-(2-imino-4,5,6,7-tetrahydro-1,3-benzothiazol-3(2H)-yl)-1-(4-methylphenyl) -1-ethanone, 2-(4-methylphenyl)-5,6,7,8-tetrahydrobenzo(d)-imidazo(2,1-b)thiazole |
| 01/03/2006 | US6982270 1-Phenyl-2-oxo-3,4-dihydro-6-phenylaminoquinazoline for example; cytokine suppressive anti-inflammatory drugs; combination therapy |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 01/03/2006 | US6982259 N-heterocyclic derivatives as NOS inhibitors |
| 01/03/2006 | US6982258 Low-calcemic oxime analogs of 1α,25-dihydroxy vitamin D3 |
| 01/03/2006 | US6982253 Liquid formulation of decitabine and use of the same |
| 01/03/2006 | CA2343236C 4,4-biarylpiperidine derivatives |
| 01/03/2006 | CA2138974C Dermatological agent for aiding oxygen transport in the skin |
| 01/03/2006 | CA2135708C Vitamin d3 analogs |
| 01/03/2006 | CA2093577C Alkyl or alkoxy substituted s-heterocyclic retinoids |
| 12/29/2005 | WO2005123671A1 Pyrrole derivative |
| 12/29/2005 | WO2005123136A1 Antiinflammatory and analgesic preparation for external use |
| 12/29/2005 | WO2005123106A1 Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester to treat sunburn and other burns |
| 12/29/2005 | WO2005123094A2 Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones |
| 12/29/2005 | WO2005123092A1 Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin d or a derivative thereof |
| 12/29/2005 | WO2005123090A1 Composition in spray form comprising a combination of a corticoid and a vitamin d derivative in an oily phase |
| 12/29/2005 | WO2005123062A1 Inflammation inhibitor comprising zinc salt of acylamino acid |
| 12/29/2005 | WO2005123058A1 Antiaging agent |
| 12/29/2005 | WO2005122794A1 Composition containing plant extract and material derived from milk |
| 12/29/2005 | WO2003033671A3 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 12/29/2005 | WO2003012122A3 Crystallized structure of type iv collagen nc1 domain hexamer |
| 12/29/2005 | US20050289660 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 12/29/2005 | US20050288501 Reducing a 2-(protected amino)-3-(piperazin-1-yl, N-morpholinyl, or N-thiomorpholinyl) propanoate, deprotecting the amine, and reacting with t-butylisothiocyanate |
| 12/29/2005 | US20050288487 Human mast cell-expressed membrane proteins |
| 12/29/2005 | US20050288376 Bicyclyl or heterobicyclylmethanesulfonylanimo-substituted N-hydroxyformamides |
| 12/29/2005 | US20050288368 Compositions and methods for treating and preventing necrosis |
| 12/29/2005 | US20050288357 e.g. 4-(2-{2-[4-hydroxy-4-(1-propylcyclobutyl)but-1-enyl]-5-oxopyrrolidin-1-yl}ethyl)benzoic acid; antiinflammatory, hypotensive, antiulcer agent |
| 12/29/2005 | US20050288356 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 12/29/2005 | US20050288350 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
| 12/29/2005 | US20050288337 Novel compounds |
| 12/29/2005 | US20050288320 Induce biosymthesis of cytokines, interferons, tumor necrosis factor; antitumor agents; viricides; chemical intermediates |
| 12/29/2005 | US20050288313 Synergistically combined with immunomodulators or antiinflammtory agents; treating rheumatoid arthritis; inhibiting organ transplant rejection; Janus Kinase 3 inhibitors such as CP 690550, 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile |
| 12/29/2005 | US20050288305 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 12/29/2005 | US20050288303 Cyclic protein tyrosine kinase inhibitors |
| 12/29/2005 | US20050288285 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 12/29/2005 | US20050288254 Treating sepsis or septic shock by administering 1-stearoyl, 1-palmitoyl-, 1-myristoyl- lysophosphatidylcholine, or 1-oleoyllysophosphatidylcholine or sphingosylphosphorylcholine. |
| 12/29/2005 | US20050288237 Novel derivative of flavone c-glycoside and composition containing the same |
| 12/29/2005 | US20050288219 Osteoprotegerin in milk |
| 12/29/2005 | US20050288211 Chemokine inhibitors; for treatment of gout; for inhibiting migration of neutrophils involved in pathogenesis |
| 12/29/2005 | US20050287546 Novel proteases |
| 12/29/2005 | US20050287232 Skin immune function controlling agents |
| 12/29/2005 | US20050287139 Wound healing |
| 12/29/2005 | DE102005027905A1 Combating stress states or nervous system or metabolic disorders, using glycine as neurotransmission modulator showing antistress, stress protective, nootropic and toxin binding actions |
| 12/29/2005 | DE102005026380A1 Mittel zur Unterdrückung von Entzündungen, umfassend Zinkpyrrolidoncarboxylat Means for suppressing inflammation, comprising zinc pyrrolidonecarboxylate |
| 12/29/2005 | DE102004045187A1 Wirkstoff, der in der Lage ist, die Überführung von inaktivem TGFb-latent in aktiven TGFb zu induzieren Agent that is capable of inducing the conversion of inactive latent TGFb-in active TGFb |
| 12/29/2005 | CA2570477A1 Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones |
| 12/29/2005 | CA2569697A1 A pharmaceutical composition and its use |
| 12/29/2005 | CA2567684A1 Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase |
| 12/29/2005 | CA2567683A1 Composition in spray form comprising a combination of a corticoid and a vitamin d derivative in an oily phase |
| 12/29/2005 | CA2567636A1 Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin d or a derivative thereof |
| 12/28/2005 | EP1609863A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/28/2005 | EP1609803A1 Modified antibody against cd22 and utilization thereof |
| 12/28/2005 | EP1609797A1 Compound having affinity with calcified tissue |
| 12/28/2005 | EP1609781A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine |
| 12/28/2005 | EP1609477A1 Irrigation solution and use thereof for the perioperative inhibition of pain/inflammation and/or spasm at a vascular structure |
| 12/28/2005 | EP1608684A2 Amphiregulin antibodies and their use to treat cancer and psoriasis |
| 12/28/2005 | EP1608381A2 Novel therapeutic application for a composition |
| 12/28/2005 | EP1608365A1 Method for treating vascular hyperpermeable disease |
| 12/28/2005 | EP1608363A1 Methods for treating inflammatory conditions or inhibiting jnk |
| 12/28/2005 | EP1608310A2 Methods and compositions for blocking the calcium cascade |
| 12/28/2005 | EP1470124B1 2-(PYRIDIN-2-YLAMINO)-PYRIDO 2,3-d]PYRIMIDIN-7-ONES |
| 12/28/2005 | EP1382604B1 Quinoline derivative having azolyl group and quinazoline derivative |
| 12/28/2005 | EP1377593B1 2-amino-propanol derivatives |
| 12/28/2005 | EP1294375B1 Treatment of seborrheic dermatitis |
| 12/28/2005 | EP1246627B1 Polyanhydrides with biologically active degradation products |
| 12/28/2005 | EP1234581B1 Use of secretory leucocyte protease inhibitor for keloid and scars |
| 12/28/2005 | EP1206242B1 Use of bacterial extracts of the pseudomonadaceae family as cosmetic agents |
| 12/28/2005 | EP1135158B1 Enhanced vaccines based on chimeric immunoglobulin e peptides |
| 12/28/2005 | EP1124810B9 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 12/28/2005 | EP0991660B1 DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS |
| 12/28/2005 | EP0716609B1 Methods and compositions for stimulating and inhibiting tgf-beta activity |
| 12/28/2005 | CN1714096A Mmp inhibitors |
| 12/28/2005 | CN1714084A Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 12/28/2005 | CN1713888A Cream for treatment of skin injured by the sun |
| 12/28/2005 | CN1233392C Paste for burns and scalds |
| 12/28/2005 | CN1233391C Psoriasis treating ointment |
| 12/28/2005 | CN1233374C Chemical for promoting growth of hairs, blackening hair and preventing sinility |
| 12/28/2005 | CN1233363C Drug for external use with functions of sterilizing and relieving itching, and its prepn. method |
| 12/28/2005 | CN1233350C Medication formulation for burn and scald |
| 12/28/2005 | CN1233343C Chinese medicinal prescription for wound and ulcer diseases |
| 12/28/2005 | CN1233342C Face beautifying agent and its manufacturing method |
| 12/28/2005 | CN1233338C Mark-removing capsule |
| 12/28/2005 | CN1233335C Exterior-applied liquid medicine for treating skin itching and its preparing process |
| 12/28/2005 | CN1233330C Extraction of Malassezia for treating chlosma, said prepn. and its prepn. method and application thereof |
| 12/28/2005 | CN1233328C Cell growth regulating factor K and its preparation process |
| 12/28/2005 | CN1233313C Usage of |
| 12/28/2005 | CN1233311C Compound ointment for treating fungous dermatosis |
| 12/28/2005 | CN1233309C Cosmetics for preventing and treating acne and its preparation process |
| 12/28/2005 | CN1233257C A composition containing carvacrol and thymol for use as abactericide |
| 12/27/2005 | US6979747 Antioxidants, preparation processes and their uses |
| 12/27/2005 | US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology |
| 12/27/2005 | US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 12/27/2005 | US6979683 Polymerase enzyme inhibitors |